iRapid

iRAPID zentralisiert Ihre RAPID-Ergebnisse mit Benachrichtigungen und konfigurierbarer PHI.

iRAPID APP FEATURES:

- Centralized Patient Results

- Custom PHI Configurability

- Custom App Notifications

- Biometric Login (FaceID & Fingerprint)

- Multifactor Authentication

*iRAPID Login required for use

iSchemaView is the world-wide leader in advanced imaging for stroke. Installed in over 1,000 stroke centers, iSchemaView’s RAPID (automated CTP, MRI, CTA and ASPECTS), with enhanced AI framework, is the most advanced stroke imaging platform.

In clinical trials, RAPID has been shown to aid in the selection of patients for therapy in early and late-window stroke trials, including SWIFT PRIME, EXTEND IA, DAWN, DEFUSE 3 and EXTEND. In addition to achieving the best clinical outcomes and largest treatment effects ever obtained, these landmark studies led to new American Heart Association and American Stroke Association guidelines and have dramatically altered the management of acute stroke around the world.